Back to search

Article

Computational Clinical Validation of Stage-conditioned Synthetic 3D FDG-PET for Alzheimer’s Disease Using Region-wise Metabolic Consistency

2026-05-21

Abstract excerpt

<title>Abstract</title> <p>Purpose Alzheimer’s disease (AD) is a progressive neurodegenerative disorder for which early diagnosis and longitudinal monitoring face two complementary constraints: ethical and practical limits on repeated Fluorodeoxyglucose Positron Emission Tomography (FDG-PET) acquisition (radiation burden, cost, scanner availability), and structural sparsity of clinically critical subgroups (e.g....

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
63c79f79-fb9a-5e27-88f8-0433cdc52b19
DOI
10.21203/rs.3.rs-9652023/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Computational Clinical Validation of Stage-conditioned Synthetic 3D FDG-PET for Alzheimer’s Disease Using Region-wise Metabolic ConsistencyDOI 10.21203/rs.3.rs-9652023/v1
Select a neighboring publication to make it the new centre.